Latest Ratios: P/E Ratio -110.0x · EV/EBITDA N/A · ROE -6.0%. (1999–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.2B | $4.3B | $4.1B | $4.2B | $4.9B | $9.1B | $5.7B | $5.1B | $3.5B | $3.8B | $2.8B |
| Enterprise Value | $6.8B | $4.0B | $3.9B | $4.0B | $4.9B | $8.5B | $6.0B | $5.3B | $3.6B | $3.9B | $2.7B |
| P/E Ratio → | -110.00 | — | — | — | 53.41 | 4.32 | 454.79 | 263.59 | 41.48 | 81.01 | 44.83 |
| P/S Ratio | 9.15 | 5.50 | 7.04 | 5.38 | 4.77 | 12.69 | 11.06 | 10.84 | 4.00 | 4.98 | 3.95 |
| P/B Ratio | 6.51 | 3.94 | 3.81 | 3.48 | 3.48 | 4.13 | 4.71 | 4.61 | 3.25 | 4.01 | 3.33 |
| P/FCF | 109.19 | 65.62 | — | — | 107.99 | — | 48.03 | 34.19 | 23.28 | 21.58 | 23.35 |
| P/OCF | 75.06 | 45.10 | — | — | 68.10 | — | 41.63 | 30.85 | 20.00 | 20.19 | 21.37 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.04 | 6.59 | 5.17 | 4.82 | 11.82 | 11.76 | 11.14 | 4.18 | 5.07 | 3.85 |
| EV / EBITDA | — | — | — | 150.19 | 28.08 | 286.81 | — | — | 26.08 | 30.74 | 25.15 |
| EV / EBIT | — | — | — | — | 37.08 | — | — | — | 39.51 | 41.99 | 40.19 |
| EV / FCF | — | 60.08 | — | — | 109.04 | — | 51.10 | 35.13 | 24.34 | 21.99 | 22.76 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.2% | 58.2% | 53.4% | 58.9% | 62.7% | 59.0% | 57.7% | 59.1% | 60.1% | 59.1% | 60.4% |
| Operating Margin | -9.0% | -9.0% | -28.3% | -3.1% | 11.6% | -4.6% | -21.0% | -18.7% | 9.8% | 11.1% | 9.5% |
| Net Profit Margin | -8.3% | -8.3% | -32.7% | -4.4% | 8.9% | 293.7% | 2.5% | 4.1% | 9.6% | 6.1% | 8.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -6.0% | -6.0% | -16.7% | -2.6% | 5.1% | 124.1% | 1.1% | 1.8% | 8.3% | 5.3% | 7.7% |
| ROA | -5.2% | -5.2% | -14.3% | -1.9% | 3.6% | 85.5% | 0.7% | 1.2% | 5.3% | 3.6% | 5.9% |
| ROIC | -6.8% | -6.8% | -13.3% | -1.5% | 5.9% | -1.6% | -5.7% | -5.4% | 5.7% | 7.1% | 6.7% |
| ROCE | -6.3% | -6.3% | -13.8% | -1.5% | 5.6% | -1.6% | -6.6% | -5.9% | 6.0% | 7.3% | 7.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.02 | 0.05 | 0.39 | 0.20 | 0.47 | 0.33 | 0.33 | 0.36 | 0.09 |
| Debt / EBITDA | — | — | — | 2.41 | 3.11 | 15.16 | — | — | 2.55 | 2.70 | 0.68 |
| Net Debt / Equity | — | -0.33 | -0.24 | -0.13 | 0.03 | -0.28 | 0.30 | 0.13 | 0.15 | 0.08 | -0.08 |
| Net Debt / EBITDA | — | — | — | -6.04 | 0.27 | -21.00 | — | — | 1.13 | 0.57 | -0.64 |
| Debt / FCF | — | -5.54 | — | — | 1.05 | — | 3.07 | 0.94 | 1.06 | 0.41 | -0.58 |
| Interest Coverage | -58.40 | -58.40 | -117.18 | -0.90 | 19.81 | -0.87 | -2.87 | -3.75 | 4.66 | 6.57 | 25.83 |
Net cash position: cash ($364M) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | 4.69 | 6.15 | 4.51 | 7.87 | 3.35 | 3.43 | 6.85 | 5.71 | 5.84 | 3.51 |
| Quick Ratio | 4.02 | 4.02 | 5.07 | 3.32 | 7.33 | 3.27 | 3.26 | 6.32 | 5.19 | 5.39 | 3.09 |
| Cash Ratio | 3.09 | 3.09 | 3.90 | 2.69 | 6.42 | 3.05 | 2.55 | 5.27 | 4.24 | 4.71 | 2.11 |
| Asset Turnover | — | 0.62 | 0.48 | 0.54 | 0.47 | 0.24 | 0.26 | 0.28 | 0.53 | 0.50 | 0.64 |
| Inventory Turnover | 3.43 | 3.43 | 2.58 | 1.66 | 3.80 | 5.99 | 4.51 | 2.65 | 4.63 | 4.30 | 4.63 |
| Days Sales Outstanding | — | 30.01 | 34.03 | 13.67 | 25.46 | 49.78 | 67.99 | 58.27 | 30.77 | 33.88 | 38.93 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 1.9% | 23.1% | 0.2% | 0.4% | 2.4% | 1.2% | 2.2% |
| FCF Yield | 0.9% | 1.5% | — | — | 0.9% | — | 2.1% | 2.9% | 4.3% | 4.6% | 4.3% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 5.2% | 18.1% | 12.6% | 0.3% | 0.5% | 1.1% | 0.0% | 1.5% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 5.2% | 18.1% | 12.6% | 0.3% | 0.5% | 1.1% | 0.0% | 1.5% |
| Shares Outstanding | — | $33M | $32M | $32M | $36M | $44M | $44M | $44M | $44M | $43M | $42M |
Persistent Operating Margin Deficit
Based on current market data, Silicon Laboratories trades at a P/S ratio of 9.18, a valuation that appears to price in significant future growth expectations despite the company's TTM negative earnings and the absence of a meaningful P/E multiple to anchor traditional fundamental valuation models.
The forward P/E of 78.95 suggests that investors are betting on a rapid return to profitability, likely driven by the company's pure-play IoT strategy. However, this valuation premium appears aggressive when compared to diversified analog peers, implying that the market is assigning a scarcity value to the firm's specialized wireless IP portfolio.
According to historical financial data, the company's ROIC has remained in negative territory, reaching -0.6% in 2026Q1, which indicates that the firm is currently failing to generate returns above its cost of capital as it navigates a challenging post-divestiture operational environment.
The persistent decay in ROIC reflects the difficulty of maintaining a high-cost R&D engine while revenue scale remains insufficient to cover fixed expenses. Investors should monitor whether the company can improve its asset utilization as the IoT design-win pipeline matures into sustained, high-margin revenue streams.
As reported in recent quarterly filings, the company's cash conversion cycle has fluctuated significantly, reaching 75 days in 2026Q1, a trend that highlights the inherent challenges in managing inventory levels within a fabless semiconductor model during periods of shifting end-market demand.
The variability in the CCC, driven largely by DIO swings, suggests that the company is still adjusting to the post-inventory correction phase. While DSO remains relatively stable, the reliance on distributor sell-in models may continue to cause lumpy working capital requirements that complicate cash flow forecasting.
Based on the most recent balance sheet, the company maintains a robust liquidity position with a current ratio of 5.11, providing a substantial safety net that allows the firm to sustain its current operating losses without immediate reliance on external debt financing or dilutive capital raises.
This strong liquidity profile is a critical defensive feature, particularly given the company's lack of long-term debt. It affords management the necessary time to right-size the cost structure and wait for the cyclical recovery in the IoT sector to translate into improved bottom-line performance.
As noted in industry research, the P/E ratio is a fundamentally flawed metric for evaluating Silicon Laboratories in its current state, as the company's negative TTM earnings render the multiple meaningless and obscure the underlying progress in its strategic IoT design-win pipeline.
Investors should instead focus on EV/Sales or forward-looking EBITDA multiples to better capture the company's growth potential and operational leverage. Relying on P/E in this context risks misinterpreting a deliberate, R&D-heavy investment phase as a permanent failure of the business model.
Includes 30+ ratios · 27 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SLAB stock.
Silicon Laboratories Inc.'s current P/E ratio is -110.0x. The historical average is 48.2x.
Silicon Laboratories Inc.'s return on equity (ROE) is -6.0%. The historical average is 12.3%.
Based on historical data, Silicon Laboratories Inc. is trading at a P/E of -110.0x. Compare with industry peers and growth rates for a complete picture.
Silicon Laboratories Inc. has 58.2% gross margin and -9.0% operating margin.